| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MLLT10 histone lysine methyltransferase DOT1L cofactor | 0.551 | 0.462 | 1.00 |
|
disease | 0.500 | None | 0.958 | 0 | 0 | 1995 | 2019 | ||||||||
|
core-binding factor subunit beta | 0.601 | 0.538 | 0.96 |
|
disease | 0.500 | None | 0.966 | 0 | 0 | 1993 | 2020 | ||||||||
|
growth factor independent 1 transcriptional repressor | 0.546 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2007 | 2020 | ||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.972 | 0 | 0 | 2000 | 2020 | ||||||||
|
myeloid leukemia factor 1 | 0.666 | 0.385 | 4.4E-09 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
phosphatidylinositol binding clathrin assembly protein | 0.592 | 0.538 | 1.00 |
|
disease | 0.490 | None | 1.000 | 0 | 0 | 2000 | 2012 | ||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.480 | None | 1.000 | 1 | 21 | 2015 | 2019 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.470 | None | 1.000 | 4 | 2 | 2011 | 2019 | ||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.450 | None | 1.000 | 1 | 30 | 2007 | 2017 | ||||||||
|
septin 9 | 0.548 | 0.769 | 1.00 |
|
disease | 0.440 | None | 1.000 | 1 | 10 | 1999 | 2017 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
disease | 0.430 | None | 1.000 | 3 | 6 | 2008 | 2018 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.430 | None | 0.800 | 1 | 4 | 1999 | 2018 | ||||||||
|
charged multivesicular body protein 5 | 0.751 | 0.192 | 6.7E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 4 | 2007 | 2017 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2001 | 2001 | ||||||||
|
cysteine rich hydrophobic domain 2 | 0.769 | 0.231 | 0.54 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 1999 | 1999 | ||||||||
|
supervillin | 0.805 | 0.231 | 8.6E-04 |
|
disease | 0.400 | None | 1.000 | 1 | 3 | 2007 | 2017 | ||||||||
|
H1.2 linker histone, cluster member | 0.722 | 0.423 | 2.8E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2007 | 2017 | ||||||||
|
protein tyrosine phosphatase receptor type T | 0.636 | 0.538 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 22 | 2017 | 2017 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.200 | None | 0.962 | 1 | 6 | 2000 | 2017 | ||||||||
|
afadin, adherens junction formation factor | 0.650 | 0.462 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 9 | 1993 | 2018 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 1998 | 2018 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 1995 | 2017 |